3 Recruiting Platinum-resistant Ovarian Cancer Phase 2 Clinical Trials
Active phase 2 studies for platinum-resistant ovarian cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Platinum-resistant Ovarian Cancer studiesPhase 2 Studies for Platinum-resistant Ovarian Cancer
🔵 Active, Not Recruiting Phase2 / Phase3
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
📍 HonorHealth Cancer Care — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
📍 Chan Soon-Shiong Institute for Medicine — El Segundo, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
📍 UCLA — Los Angeles, California
View Study & Checklist ➔